Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 6 |
Descriptor
Neonates | 6 |
Diseases | 3 |
Genetic Disorders | 3 |
Medical Services | 3 |
Premature Infants | 3 |
Screening Tests | 3 |
At Risk Persons | 2 |
Hospitals | 2 |
Metabolism | 2 |
African Americans | 1 |
Altruism | 1 |
More ▼ |
Source
Developmental Disabilities… | 6 |
Author
Boss, Renee D. | 1 |
Donahue, Pamela K. | 1 |
Graham, Ernest | 1 |
Lantos, John D. | 1 |
Matern, Dietrich | 1 |
Oglesbee, Devin | 1 |
Robinson, Karen A. | 1 |
Stewart, Amanda | 1 |
Tan, Christopher A. | 1 |
Tortorelli, Silvia | 1 |
Waggoner, Darrel J. | 1 |
More ▼ |
Publication Type
Journal Articles | 6 |
Reports - Descriptive | 6 |
Education Level
Audience
Location
New York | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Matern, Dietrich; Oglesbee, Devin; Tortorelli, Silvia – Developmental Disabilities Research Reviews, 2013
Newborn screening (NBS) is a public health program aimed at identifying treatable conditions in presymptomatic newborns to avoid premature mortality, morbidity, and disabilities. Currently, every newborn in the Unites States is screened for at least 29 conditions where evidence suggests that early detection is possible and beneficial. With new or…
Descriptors: Genetic Disorders, Neurological Impairments, Neonates, Health Programs
Lantos, John D. – Developmental Disabilities Research Reviews, 2011
Public policy surrounding newborn screening is in flux. New technology allows more screening for more diseases at lower cost. Traditional criteria for target diseases have been criticized by leading health policymakers. The example of newborn screening for Krabbe disease highlights many of the dilemmas associated with population-based screening…
Descriptors: Pilot Projects, Diseases, Neonates, Public Policy
Waggoner, Darrel J.; Tan, Christopher A. – Developmental Disabilities Research Reviews, 2011
Newborn screening (NBS), since its implementation in the 1960s, has traditionally been successful in reducing mortality and disability in children with a range of different conditions. Lysosomal storage disorders (LSD) are a heterogeneous group of inherited metabolic diseases that result from lysosomal dysfunction. Based on available treatment and…
Descriptors: Disability Identification, Reading Achievement, Screening Tests, Neonates
Donahue, Pamela K.; Robinson, Karen A. – Developmental Disabilities Research Reviews, 2010
Few interventions and treatments for premature infants have undergone the rigors of a randomized controlled trial (RCT), the cornerstone of evidence-based healthcare. Multiple barriers in establishing a quality evidence base for the care of preterm infants are examined including the systematic exclusion of children from drug trials, vulnerability…
Descriptors: Evidence, Premature Infants, At Risk Persons, Barriers
Boss, Renee D. – Developmental Disabilities Research Reviews, 2010
Extremely premature infants face multiple acute and chronic life-threatening conditions. In addition, the treatments to ameliorate or cure these conditions often entail pain and discomfort. Integrating palliative care from the moment that extremely premature labor is diagnosed offers families and clinicians support through the process of defining…
Descriptors: Family Programs, Premature Infants, Diseases, Neonates
Stewart, Amanda; Graham, Ernest – Developmental Disabilities Research Reviews, 2010
Preterm birth is the leading cause of neonatal mortality and a major public health concern. Risk factors for preterm birth include a history of preterm birth, short cervix, infection, short interpregnancy interval, smoking, and African-American race. The use of progesterone therapy to treat mothers at risk for preterm delivery is becoming more…
Descriptors: Public Health, Pregnancy, Premature Infants, At Risk Persons